CLINICAL_TRIALS
withdrawal
· 2026-01-08
Clinical Trial Update: Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children [Phase 2, Phase 3]
Summary
A cystinuria trial (Phase 2/Phase 3) sponsored by Advicenne Pharma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Advicenne Pharma | Conditions: Cystinuria | Phase 2, Phase 3 | Status: WITHDRAWN